PBSV news

Pharma-Bio Serv reported increasing revenues for the three and nine months ended July 31, 2026, alongside a significant improvement in net income year-over-year. The company cites strong client relationships and operational efficiencies as key drivers for the financial performance.

Pharma-Bio Serv posted revenues of $2.7 million for the three months ended April 30, 2026, up $0.3 million year-over-year, with net income increasing $0.1 million to $0.2 million. The compliance and regulatory consulting firm attributed improved profitability to strategic market focus and discipline…